Plexus Accelerator - Does it contain DMAA or not?

Australia and Canada Government say YES

DMAA found by Australians

Plexus Slim Accelerator capsules and Plexus Slim Accelerator 3 Day Trial pack

Safety advisory

16 July 2013
Plexus slim accelerator pill bottlePlexus Slim Accelerator capsules and Plexus Slim Accelerator 3 Day Trial pack pose a serious risk to your health and should not be taken.
The Therapeutic Goods Administration (TGA) has tested Plexus Slim Accelerator capsules and Plexus Slim Accelerator 3 Day Trial pack capsules and found that:
  • They contain the undeclared banned chemical 1,3-dimethylamylamine (DMAA)
  • Consumers are advised that DMAA is listed in Appendix C of the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP). Substances within Appendix C are of such danger to health as to warrant prohibition of sale, supply and use.
  • Risks associated with its use include high blood pressure, psychiatric disorders, bleeding in the brain and stroke.
Further information about DMAA can be found on the TGA website:
The supply of Plexus Slim Accelerator capsules and Plexus Slim Accelerator 3 Day Trial pack is illegal.
Plexus slim accelerator 3 day trial packPlexus Slim Accelerator capsules and Plexus Slim Accelerator 3 Day Trial pack have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.
TGA investigations have shown that a number of people in Australia have bought the product online.

Information for consumers

  • Stop taking Plexus Slim Accelerator capsules and Plexus Slim Accelerator 3 Day Trial pack and take any remaining capsules to your local pharmacy forsafe disposal(link is external).
  • If you have any concerns arising from your use of this product, consult your health care practitioner.

Action the TGA is taking

The TGA is working with Australian Customs and Border Protection Services (Customs) to help stop future shipments of Plexus Slim Accelerator capsules and Plexus Slim Accelerator 3 Day Trial pack from entering Australia.
The TGA is advising consumers to exercise extreme caution when purchasing medicines from unknown overseas Internet sites(link is external). Products purchased over the Internet:
  • may contain undisclosed and potentially harmful ingredients
  • may not meet the same standards of quality, safety and efficacy as those approved by the TGA for supply in Australia.

Report counterfeit medicines and medical devices

If you are worried about counterfeit medicines or medical devices(link is external), and want to report an issue, you can report the matter to the TGA:

DMAA found by Canadians:


Foreign Product Alert: Plexus Slim Accelerator capsules, and Plexus Slim Accelerator 3 Day Trial pack

Starting date:
February 7, 2014
Posting date:
February 7, 2014
Type of communication:
Foreign Product Alert (FPA)
Subcategory:
Natural health products
Source of recall:
Health Canada
Source of alert:
Australia Therapeutic Goods Administration
Issue:
Undeclared Substance
Audience:
General Public
Identification number:
RA-37721

Introduction

These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.

Affected products

  • Plexus Slim Accelerator capsules
  • Plexus Slim Accelerator 3 Day Trial pack

Plexus Slim Accelerator capsules, and Plexus Slim Accelerator 3 Day Trial pack

Product description

These products are promoted for weight loss.

Hazard identified

The Australia Therapeutic Goods Administration (TGA) warned consumers not to use these products as they were found to contain 1,3-dimethylamylamine (DMAA), a drug that is not approved for sale in Canada.
Health Canada received one Canadian report of a serious adverse reaction suspected to be associated with a "Plexus Slim Accelerator" product.  Due to limited information at this time, Health Canada is unable to determine whether the product reported is the same as the product that is the subject of the TGA alert, or what role, if any, the product may have played in the adverse reaction. It is not known where the product was purchased. Health Canada is currently following up on this report.

Place of origin

Unknown

Side effects

Side effects associated with DMAA include high blood pressure, shortness of breath, chest pain, stroke and psychiatric disorders.

What you should do

Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find either of the products listed above in the Canadian marketplace.
Canadians who have these products are advised not to use them, and should consult with a health care professional if they have concerns about their health related to the use of these products.

Background

Drugs and natural health products that are authorized for sale in Canada will have an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.
As of December 31, 2013, Health Canada has received one report of an adverse reaction suspected to be associated with the use of these products.

Report a health of safety concern

To report a side effect to a health product to Health Canada:
  • Call toll-free at 1-866-234-2345
  • Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax

What is DMAA


DMAA, IS AN INGREDIENT FOUND ILLEGALLY IN SOME DIETARY SUPPLEMENTS AND OFTEN TOUTED AS A “NATURAL” STIMULANT. 

DMAA, ESPECIALLY IN COMBINATION WITH OTHER INGREDIENTS SUCH AS CAFFEINE, CAN BE A HEALTH RISK TO CONSUMERS. 
INGESTION OF DMAA CAN:

  • ELEVATE BLOOD PRESSURE
  • LEAD TO CARDIOVASCULAR PROBLEMS
  • SHORTNESS OF BREATH
  • TIGHTENING IN THE CHEST
  •  HEART ATTACK







DIETARY SUPPLEMENTS CONTAINING DMAA ARE ILLEGAL.

Other Names to look for that identify DMAA:

 1,3-dimethylamylamine
 1,3-dimethylpentylamine
 2-amino-4-methylhexane
 2-hexanamine,4-methyl-(9Cl)
 4-methyl-2-hexanamine
 4-methyl-2-hexylamine
 4-methylhexan-2-amine (IUPAC)
 C7H17N (chemical formula)
 CAS 105-41-9
 Crane's bill extract 200:1 (misnomer;
not necessarily DMAA)
 dimethylamylamine (DMAA)
 dimethylpentylamine (DMP)
 DMAA
 Floradrene
 Forthan
 Forthane
 Fouramin
 Geranamine (Proviant™)
 GeranaX
 Geranium extract
 Geranium flower extract
 Geranium oil
 Geranium oil extract
 Geranium stems and leaves
 Metexaminum
 Methexaminum
 Methylhexanamine
 Methylhexaneamine (MHA)
 Pelargonium (various)
 Pentylamine
 synthetic geranium

METHYLPENTANE

Methylpentane is a chemical that is similar to the unsafe chemical 1,3-dimethylamylamine (DMAA) that has been banned by the US Food and Drug Administration. It is commonly found in supplements that claim to help people lose weight, improve athletic performance, and improve brain function.

Other Names:

  • DMBA
  • AMP Citrate

Products with Methylpentane:

  • TruVision Health - TruWEIGHT&ENERGY

No comments:

Post a Comment